Across TCGA pan-cancer cohorts, CDY23P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated CDY23P data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CDY23P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY23P expression acts as an unfavorable survival marker.
COAD are the cancer types where CDY23P RNA most reproducibly stratifies survival.